HTML has links - PDF has Authentication
246-221-010  <<  246-221-015 >>   246-221-020

PDFWAC 246-221-015

Compliance with requirements for summation of external and internal doses.

(1) If the licensee is required to monitor under both WAC 246-221-090 and 246-221-100, the licensee shall demonstrate compliance with the dose limits by summing external and internal doses. If the licensee is required to monitor only under WAC 246-221-090 or only under WAC 246-221-100, then summation is not required to demonstrate compliance with the dose limits. The licensee may demonstrate compliance with the requirements for summation of external and internal doses under subsections (2), (3), and (4) of this section. The dose equivalents for the lens of the eye, the skin, and the extremities are not included in the summation, but are subject to separate limits.
(2) Intake by inhalation. If the only intake of radionuclides is by inhalation, the total effective dose equivalent limit is not exceeded if the sum of the deep dose equivalent divided by the total effective dose equivalent limit, and one of the following, does not exceed unity:
(a) The sum of the fractions of the inhalation ALI for each radionuclide; or
(b) The total number of derived air concentration-hours (DAC-hours) for all radionuclides divided by 2,000; or
(c) The sum of the calculated committed effective dose equivalents to all significantly irradiated organs or tissues (T) calculated from bioassay data using appropriate biological models and expressed as a fraction of the annual limit. For purposes of this requirement, an organ or tissue is deemed to be significantly irradiated if, for that organ or tissue, the product of the weighting factors, wT, and the committed dose equivalent, HT,50, per unit intake is greater than 10 percent of the maximum weighted value of H50, that is, wTHT,50, per unit intake for any organ or tissue.
(3) Intake by oral ingestion. If the occupationally exposed individual also receives an intake of radionuclides by oral ingestion greater than 10 percent of the applicable oral ALI, the licensee shall account for this intake and include it in demonstrating compliance with the limits.
(4) Intake through wounds or absorption through skin. The licensee shall evaluate and, to the extent practical, account for intakes through wounds or skin absorption. The intake through intact skin has been included in the calculation of DAC for hydrogen-3 and does not need to be evaluated or accounted for pursuant to this section.
(5) External dose from airborne radioactive material. Licensees shall, when determining the dose from airborne radioactive material, include the contribution to the deep dose equivalent, lens dose equivalent, and shallow dose equivalent from external exposure to the radioactive cloud. Airborne radioactivity measurements and DAC values shall not be used as the primary means to assess the deep dose equivalent when the airborne radioactive material includes radionuclides other than noble gases or if the cloud of airborne radioactive material is not relatively uniform. The determination of the deep dose equivalent to an individual shall be based upon measurements using instruments or individual monitoring devices.
[Statutory Authority: RCW 70A.388.040 and 70A.388.110. WSR 23-21-056, § 246-221-015, filed 10/11/23, effective 11/11/23. Statutory Authority: RCW 70.98.050. WSR 01-05-110, § 246-221-015, filed 2/21/01, effective 3/24/01; WSR 94-01-073, § 246-221-015, filed 12/9/93, effective 1/9/94.]
Site Contents
Selected content listed in alphabetical order under each group